$FSNUY News

Vizient Expands Supply Assurance for IV Solutions Through Collaboration With Fresenius Kabi

Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion

Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion

Fresenius Kabi Receives Pharmacy Strategic Programs Excellence Award From Vizient®

Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform

Sandoz Partners With Fresenius Unit mAbxience On Licensing, Development, Manufacturing And Commercialization For An Emicizumab Biosimilar Candidate

Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?

All You Need to Know About Fresenius SE & Co. (FSNUY) Rating Upgrade to Buy

Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?

Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ...

Fresenius SE & Co. KGaA (FSNUY) Q2 2026 Earnings Call Transcript

Fresenius SE & Co. KGaA 2026 Q2 - Results - Earnings Call Presentation

Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market

Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate

Fresenius (XTRA:FRE) Stock May Still Be Cheap On Its 66% Run

Fresenius establishes venture fund of more than €200 million to drive healthcare innovation

Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?

Fresenius SE & Co. KGaA (FSNUY) Q1 2026 Earnings Call Transcript

Fresenius SE & Co. KGaA 2026 Q1 - Results - Earnings Call Presentation

Health Industry Must Navigate a New World Order: Fresenius CEO